CABIO Biotech (Wuhan)
¥8.53
0
+¥0.08+0.95% Friday 06:56
Statistics
Day High
8.53
Day Low
8.5
52W High
28.64
52W Low
6.91
Volume
2,252
Avg. Volume
-
Mkt Cap
963.89M
P/E Ratio
32.18
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jul 25
¥0.20
Jun 24
¥0.20
Jul 23
¥0.21
Jul 22
¥0.24
Jul 21
¥0.24
10Y Growth
N/A
5Y Growth
-10.87%
3Y Growth
-5.18%
1Y Growth
0.47%
Earnings
26OctExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q1 2026
Next
0.14
0.17
0.2
0.23
Expected EPS
N/A
Actual EPS
N/A
Financials
26.54%Profit Margin
Profitable541.64MRevenue
143.73MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
Show more...
CEO
De Wei Yi
Employees
595
Country
China
ISIN
CNE100005X31
Listings
0 Comments
Share your thoughts
FAQ
What is CABIO Biotech (Wuhan) stock price today?▼
The current price of 688089.SHG is ¥8.53 CNY — it has increased by +0.95% in the past 24 hours. Watch CABIO Biotech (Wuhan) stock price performance more closely on the chart.
What is CABIO Biotech (Wuhan) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shanghai Stock Exchange exchange CABIO Biotech (Wuhan) stocks are traded under the ticker 688089.SHG.
Is CABIO Biotech (Wuhan) stock price growing?▼
688089.SHG stock has risen by +5.83% compared to the previous week, the month change is a +9.64% rise, over the last year CABIO Biotech (Wuhan) has showed a -67.91% decrease.
What is CABIO Biotech (Wuhan) market cap?▼
Today CABIO Biotech (Wuhan) has the market capitalization of 963.89M
When is the next CABIO Biotech (Wuhan) earnings date?▼
CABIO Biotech (Wuhan) is going to release the next earnings report on October 26, 2026.
What is CABIO Biotech (Wuhan) revenue for the last year?▼
CABIO Biotech (Wuhan) revenue for the last year amounts to 541.64M CNY.
What is CABIO Biotech (Wuhan) net income for the last year?▼
688089.SHG net income for the last year is 143.73M CNY.
Does CABIO Biotech (Wuhan) pay dividends?▼
Yes, 688089.SHG dividends are paid annual. The last dividend per share was 0.2 CNY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does CABIO Biotech (Wuhan) have?▼
As of September 06, 2026, the company has 595 employees.
In which sector is CABIO Biotech (Wuhan) located?▼
CABIO Biotech (Wuhan) operates in the Health & Wellness sector.
When did CABIO Biotech (Wuhan) complete a stock split?▼
The last stock split for CABIO Biotech (Wuhan) was on July 18, 2023 with a ratio of 1.4:1.
Where is CABIO Biotech (Wuhan) headquartered?▼
CABIO Biotech (Wuhan) is headquartered in Wuhan, China.